Lymphoma, Large-Cell Completed Phase 1 / 2 Trials for SGN-30 (DB05471)

Also known as: Large-cell Lymphoma

IndicationStatusPhase
DBCOND0030182 (Lymphoma, Large-Cell)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00051597A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesTreatment